A detailed history of Nvwm, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Nvwm, LLC holds 426 shares of AMPH stock, worth $17,397. This represents 0.01% of its overall portfolio holdings.

Number of Shares
426
Previous 408 4.41%
Holding current value
$17,397
Previous $16,000 25.0%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$36.99 - $50.09 $665 - $901
18 Added 4.41%
426 $20,000
Q2 2024

Aug 13, 2024

BUY
$38.65 - $43.48 $2,087 - $2,347
54 Added 15.25%
408 $16,000
Q1 2024

May 06, 2024

SELL
$42.85 - $63.45 $385 - $571
-9 Reduced 2.48%
354 $15,000
Q4 2023

Feb 07, 2024

BUY
$44.49 - $62.93 $7,963 - $11,264
179 Added 97.28%
363 $22,000
Q3 2023

Oct 30, 2023

BUY
$45.51 - $65.0 $8,373 - $11,960
184 New
184 $8,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Nvwm, LLC Portfolio

Follow Nvwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nvwm, LLC with notifications on news.